Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$277.25 - $366.29 $418,370 - $552,731
-1,509 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$300.63 - $371.35 $90,189 - $111,405
-300 Reduced 16.58%
1,509 $542,000
Q3 2021

Nov 12, 2021

SELL
$310.19 - $376.2 $44,667 - $54,172
-144 Reduced 7.37%
1,809 $589,000
Q2 2021

Aug 10, 2021

BUY
$262.71 - $351.17 $279,260 - $373,293
1,063 Added 119.44%
1,953 $610,000
Q1 2021

May 12, 2021

SELL
$285.92 - $355.13 $5,146 - $6,392
-18 Reduced 1.98%
890 $284,000
Q4 2020

Feb 10, 2021

SELL
$251.88 - $324.2 $352,632 - $453,880
-1,400 Reduced 60.66%
908 $294,000
Q3 2020

Nov 12, 2020

BUY
$255.22 - $317.0 $589,047 - $731,636
2,308 New
2,308 $639,000
Q1 2020

May 13, 2020

SELL
$130.51 - $196.01 $2.09 Million - $3.13 Million
-15,992 Closed
0 $0
Q4 2019

Feb 10, 2020

SELL
$159.31 - $223.54 $39,030 - $54,767
-245 Reduced 1.51%
15,992 $2.73 Million
Q3 2019

Nov 12, 2019

BUY
$175.89 - $279.23 $307,455 - $488,094
1,748 Added 12.06%
16,237 $2.89 Million
Q2 2019

Aug 09, 2019

BUY
$250.96 - $284.94 $2.82 Million - $3.2 Million
11,241 Added 346.09%
14,489 $3.77 Million
Q1 2019

May 13, 2019

SELL
$276.39 - $362.25 $103,646 - $135,843
-375 Reduced 10.35%
3,248 $928,000
Q4 2018

Feb 06, 2019

SELL
$281.08 - $444.25 $656,883 - $1.04 Million
-2,337 Reduced 39.21%
3,623 $1.18 Million
Q3 2018

Nov 08, 2018

BUY
$354.53 - $449.75 $1.19 Million - $1.5 Million
3,343 Added 127.74%
5,960 $2.68 Million
Q2 2018

Aug 14, 2018

BUY
$278.07 - $446.21 $599,796 - $962,474
2,157 Added 468.91%
2,617 $1.07 Million
Q1 2018

May 11, 2018

SELL
$192.49 - $295.85 $448,886 - $689,922
-2,332 Reduced 83.52%
460 $134,000
Q4 2017

Feb 09, 2018

BUY
$168.78 - $199.74 $454,018 - $537,300
2,690 Added 2637.25%
2,792 $523,000
Q3 2017

Nov 15, 2017

BUY
$145.39 - $168.6 $5,960 - $6,912
41 Added 67.21%
102 $17,000
Q2 2017

Aug 14, 2017

BUY
N/A
61
61 $9,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.